EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Mobile health apps improve Health-Related Quality of Life in Type 2 Diabetes Mellitus by enhancing medication adherence: A multicentre randomised controlled trial with mediation analysis

Mohd Syamir Mohamad Shukeri, Baharudin Ibrahim, Siew Chin Ong, Hasniza Zaman Huri, Rajat Rana, Tooba Malik, Chow Kyn Ng

Primary Care Diabetes · 2026

DOI: 10.1016/j.pcd.2026.08.001 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Primary Care Diabetes, 2026. Verfasst von Mohd Syamir Mohamad Shukeri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia; Pharmacy Department, Ins…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Quality of Life, Medication Adherence, Hypoglycemic Agents. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study evaluated whether a gamified mHealth application (CareAide®) improves Health-Related Quality of Life (HRQoL) in Type 2 Diabetes Mellitus (T2DM) and whether this effect is mediated by medication adherence. METHODS: Prespecified secondary analysis of the T2DM cohort from a 6-month multicentre RCT (NCT06068309; N = 663; three Malaysian hospitals). Participants were randomised 1:1 to standard care or CareAide®. Adherence (MMAS-8), EQ-5D-5L utility (Malaysian value set), and AQoL-6D were assessed at baseline and 6 months. Simple mediation analysis (PROCESS Model 4; 5000 bootstraps) adjusted for baseline HRQoL. RESULTS: CareAide® significantly predicted higher MMAS-8 scores (mean difference +1.756; d = 1.638; p < 0.001). Higher MMAS-8 scores significantly predicted improved AQoL-6D utility (b = 0.024; p < 0.001). The direct effect on AQoL-6D was non-significant (p = 0.248). Bootstrapped indirect effect confirmed full mediation via AQoL-6D (0.042; 95% CI [0.024, 0.060]). A sensitivity analysis adjusting for baseline HbA1c confirmed full mediation (indirect = 0.034; 95% CI [0.015, 0.052]; n = 563). EQ-5D-5L utility showed a significant direct between-group difference at 6 months (p = 0.012) but did not operate as a mediation outcome. CONCLUSIONS: Medication adherence fully mediates the AQoL-6D HRQoL benefit of a gamified mHealth intervention in T2DM, as confirmed by both the primary and HbA1c-adjusted sensitivity analyses. These findings support integration of behaviourally informed digital adjuncts into routine primary diabetes care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Quality of LifeMedication AdherenceHypoglycemic AgentsMobile ApplicationsTelemedicineGlycemic ControlHumansFemaleMiddle AgedMaleTreatment OutcomeMalaysiaAdherence InterventionsAgedTime FactorsMediation AnalysisDigital HealthBiomarkers

Stichwörter der Autor:innen

HRQoLMediation analysisMedication adherenceRandomised controlled trialType 2 Diabetes MellitusmHealth

Substanzen

Hypoglycemic AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia; Pharmacy Department, Institut Kanser Negara, Putrajaya 62250, Malaysia.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia. Electronic address: baharudin.ibrahim@um.edu.my.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia. Electronic address: siewchinong@usm.my.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.

Zitieren

APA

Mohamad Shukeri, M. S., Ibrahim, B., Ong, S. C., Zaman Huri, H., Rana, R., Malik, T., & Ng, C. K. (2026). Mobile health apps improve Health-Related Quality of Life in Type 2 Diabetes Mellitus by enhancing medication adherence: A multicentre randomised controlled trial with mediation analysis. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2026.08.001

Vancouver

Mohamad Shukeri MS, Ibrahim B, Ong SC, Zaman Huri H, Rana R, Malik T, et al. Mobile health apps improve Health-Related Quality of Life in Type 2 Diabetes Mellitus by enhancing medication adherence: A multicentre randomised controlled trial with mediation analysis. Primary Care Diabetes. 2026. doi:10.1016/j.pcd.2026.08.001

BibTeX
@article{MohamadShukeri2026,
  author = {Mohamad Shukeri, Mohd Syamir and Ibrahim, Baharudin and Ong, Siew Chin and Zaman Huri, Hasniza and Rana, Rajat and Malik, Tooba and Ng, Chow Kyn},
  title = {Mobile health apps improve Health-Related Quality of Life in Type 2 Diabetes Mellitus by enhancing medication adherence: A multicentre randomised controlled trial with mediation analysis},
  journal = {Primary Care Diabetes},
  year = {2026},
  doi = {10.1016/j.pcd.2026.08.001}
}
Kostenlos starten →